Takeda Pharmaceutical Company Limited (TYO:4502)
Japan · Delayed Price · Currency is JPY 4,273.00
+51.00 (1.21%)
Oct 21, 2025, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,455 employees as of March 31, 2025. The number of employees decreased by 1,826 or -3.71% compared to the previous year.
Employees
47,455
Change (1Y)
-1,826
Growth (1Y)
-3.71%
Revenue / Employee
94.41M JPY
Profits / Employee
2.89M JPY
Market Cap
6.59T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | 47,099 | -396 | -0.83% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| HOYA Corporation | 37,909 |
| Otsuka Holdings | 35,338 |
| Olympus | 29,297 |
| Daiichi Sankyo Company | 19,765 |
| M3, Inc. | 15,360 |
| Astellas Pharma | 13,643 |
| Eisai | 10,917 |
| Kyowa Kirin | 5,669 |
Takeda Pharmaceutical Company News
- 6 days ago - Takeda Taps Nabla Bio's Generative AI Platform For Antibody Design In $1 Billion Pact - Benzinga
- 7 days ago - US biotech Nabla Bio, Japan's Takeda expand AI drug design partnership - Reuters
- 7 days ago - Nabla Bio Signs Second Takeda Collaboration to Advance AI-Driven Design of Protein Therapeutics - Business Wire
- 11 days ago - Takeda Pharmaceutical Becomes Oversold (TAK) - Nasdaq
- 19 days ago - Takeda Pharmaceutical to exit cell therapy research - Reuters
- 20 days ago - Bristol Myers, Takeda to pool data for AI-based drug discovery - Reuters
- 20 days ago - TAK Makes Notable Cross Below Critical Moving Average - Nasdaq
- 25 days ago - Shares of Asian drugmakers drop after Trump threatens tariffs - Reuters